HELIX alpha is further strengthening its European platform and expanding the specialist capabilities it offers across Life Science Real Estate. As of 1 October 2026, Patrick Schlump will join HELIX alpha as Managing Partner and shareholder, taking a leading role in Fund Management, Client Relations and Equity Raising. Most recently with France-based Praemia REIM, Patrick brings extensive experience in European investment and fund management. He and HELIX alpha founder and CEO Martin Eberhardt...

Martin Eberhardt FRICS, CEO & Founder of HELIX alpha, spoke at the CBRE Life Sciences Summit in Berlin on the topic of “Infrastructure & Capitalization Gap in Life Science Real Estate”. The summit brought together senior representatives from across the European Life Science Real Estate sector, including corporates, developers, investors, operators, banks and advisors, to discuss the requirements for the further development of the sector and the role of real estate and capital in supporting...

Martin Eberhardt FRICS, CEO & Founder of HELIX alpha, will participate in a panel discussion on the specific challenges of valuing Social Infrastructure, including Life Science Real Estate, at the RICS Valuation Conference in Frankfurt am Main on 22 September 2026. The valuation of Life Science Real Estate presents particular challenges for valuers and investors. The European market is still comparatively young, with a limited number of investment transactions and reliable comparable data. At...